nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Fentanyl—Diphenhydramine—atopic dermatitis	0.48	1	CrCrCtD
Remifentanil—OPRK1—GPCR ligand binding—CCL27—atopic dermatitis	0.0007	0.00515	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000696	0.00512	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.000682	0.00502	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—CCR3—atopic dermatitis	0.000681	0.00501	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—CCR5—atopic dermatitis	0.00068	0.005	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.000679	0.00499	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000664	0.00489	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CCL22—atopic dermatitis	0.000663	0.00488	CbGpPWpGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00065	0.00479	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000632	0.00465	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00063	0.00464	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CCL17—atopic dermatitis	0.000627	0.00462	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000617	0.00454	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.000608	0.00447	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.000608	0.00447	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.000596	0.00439	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.000595	0.00438	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CCL27—atopic dermatitis	0.000591	0.00435	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CCL11—atopic dermatitis	0.000577	0.00424	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—NFKBIA—atopic dermatitis	0.000576	0.00424	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—CCR3—atopic dermatitis	0.000576	0.00423	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00057	0.0042	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000561	0.00413	CbGpPWpGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00056	0.00412	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000552	0.00406	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00055	0.00405	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00055	0.00405	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000549	0.00404	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000541	0.00398	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00054	0.00397	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000534	0.00393	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CCL17—atopic dermatitis	0.00053	0.0039	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CCL11—atopic dermatitis	0.000506	0.00372	CbGpPWpGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000504	0.00371	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.000503	0.0037	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000491	0.00361	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000483	0.00355	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000483	0.00355	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000482	0.00355	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000481	0.00354	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000473	0.00348	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000472	0.00348	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CCR3—atopic dermatitis	0.00047	0.00346	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000467	0.00344	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCL22—atopic dermatitis	0.000459	0.00338	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000458	0.00337	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000451	0.00332	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000442	0.00325	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000436	0.00321	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CCL11—atopic dermatitis	0.000427	0.00315	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—CD4—atopic dermatitis	0.000427	0.00314	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000426	0.00313	CbGpPWpGaD
Remifentanil—Haemorrhage—Methylprednisolone—atopic dermatitis	0.000422	0.0011	CcSEcCtD
Remifentanil—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000422	0.0011	CcSEcCtD
Remifentanil—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000422	0.0011	CcSEcCtD
Remifentanil—Hallucination—Methylprednisolone—atopic dermatitis	0.00042	0.00109	CcSEcCtD
Remifentanil—Pharyngitis—Triamcinolone—atopic dermatitis	0.00042	0.00109	CcSEcCtD
Remifentanil—OPRD1—GPCR ligand binding—NPS—atopic dermatitis	0.000419	0.00308	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—TAC1—atopic dermatitis	0.000419	0.00308	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000415	0.00305	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000414	0.00305	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CCR3—atopic dermatitis	0.000412	0.00303	CbGpPWpGaD
Remifentanil—Arrhythmia—Prednisolone—atopic dermatitis	0.000411	0.00107	CcSEcCtD
Remifentanil—OPRD1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000411	0.00302	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCL27—atopic dermatitis	0.000409	0.00301	CbGpPWpGaD
Remifentanil—Vomiting—Mometasone—atopic dermatitis	0.000409	0.00106	CcSEcCtD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000408	0.003	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000408	0.003	CbGpPWpGaD
Remifentanil—Visual impairment—Methylprednisolone—atopic dermatitis	0.000407	0.00106	CcSEcCtD
Remifentanil—Urticaria—Tacrolimus—atopic dermatitis	0.000407	0.00106	CcSEcCtD
Remifentanil—OPRM1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000407	0.00299	CbGpPWpGaD
Remifentanil—Immune system disorder—Hydrocortisone—atopic dermatitis	0.000406	0.00106	CcSEcCtD
Remifentanil—Rash—Mometasone—atopic dermatitis	0.000406	0.00106	CcSEcCtD
Remifentanil—Dermatitis—Mometasone—atopic dermatitis	0.000405	0.00105	CcSEcCtD
Remifentanil—Body temperature increased—Tacrolimus—atopic dermatitis	0.000405	0.00105	CcSEcCtD
Remifentanil—Headache—Mometasone—atopic dermatitis	0.000403	0.00105	CcSEcCtD
Remifentanil—OPRK1—Signaling by GPCR—CCL22—atopic dermatitis	0.000403	0.00296	CbGpPWpGaD
Remifentanil—Arrhythmia—Hydrocortisone—atopic dermatitis	0.000402	0.00104	CcSEcCtD
Remifentanil—Erythema—Prednisolone—atopic dermatitis	0.000401	0.00104	CcSEcCtD
Remifentanil—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.0004	0.00104	CcSEcCtD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.0004	0.00294	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000395	0.00291	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000395	0.00291	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—IL1B—atopic dermatitis	0.000394	0.0029	CbGpPWpGaD
Remifentanil—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000392	0.00102	CcSEcCtD
Remifentanil—Erythema—Hydrocortisone—atopic dermatitis	0.000391	0.00102	CcSEcCtD
Remifentanil—Bradycardia—Dexamethasone—atopic dermatitis	0.000391	0.00102	CcSEcCtD
Remifentanil—Bradycardia—Betamethasone—atopic dermatitis	0.000391	0.00102	CcSEcCtD
Remifentanil—Haemoglobin—Dexamethasone—atopic dermatitis	0.000386	0.001	CcSEcCtD
Remifentanil—Haemoglobin—Betamethasone—atopic dermatitis	0.000386	0.001	CcSEcCtD
Remifentanil—Haemorrhage—Dexamethasone—atopic dermatitis	0.000384	0.000999	CcSEcCtD
Remifentanil—Haemorrhage—Betamethasone—atopic dermatitis	0.000384	0.000999	CcSEcCtD
Remifentanil—Angiopathy—Methylprednisolone—atopic dermatitis	0.000383	0.000997	CcSEcCtD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000383	0.00281	CbGpPWpGaD
Remifentanil—Hallucination—Dexamethasone—atopic dermatitis	0.000382	0.000994	CcSEcCtD
Remifentanil—Hallucination—Betamethasone—atopic dermatitis	0.000382	0.000994	CcSEcCtD
Remifentanil—Nausea—Mometasone—atopic dermatitis	0.000382	0.000994	CcSEcCtD
Remifentanil—Immune system disorder—Methylprednisolone—atopic dermatitis	0.000382	0.000993	CcSEcCtD
Remifentanil—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000381	0.00099	CcSEcCtD
Remifentanil—Arrhythmia—Triamcinolone—atopic dermatitis	0.000378	0.000984	CcSEcCtD
Remifentanil—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000377	0.000982	CcSEcCtD
Remifentanil—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000377	0.000982	CcSEcCtD
Remifentanil—Hyperglycaemia—Prednisone—atopic dermatitis	0.000377	0.000981	CcSEcCtD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000376	0.00276	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000374	0.00275	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000373	0.00275	CbGpPWpGaD
Remifentanil—Visual impairment—Betamethasone—atopic dermatitis	0.00037	0.000963	CcSEcCtD
Remifentanil—Visual impairment—Dexamethasone—atopic dermatitis	0.00037	0.000963	CcSEcCtD
Remifentanil—Erythema—Triamcinolone—atopic dermatitis	0.000369	0.000959	CcSEcCtD
Remifentanil—Erythema—Methylprednisolone—atopic dermatitis	0.000368	0.000957	CcSEcCtD
Remifentanil—OPRK1—GPCR ligand binding—TAC1—atopic dermatitis	0.000367	0.0027	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—NPS—atopic dermatitis	0.000367	0.0027	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCL17—atopic dermatitis	0.000367	0.0027	CbGpPWpGaD
Remifentanil—Pruritus—Tacrolimus—atopic dermatitis	0.000362	0.000943	CcSEcCtD
Remifentanil—OPRM1—TCR Signaling Pathway—MAPK8—atopic dermatitis	0.000361	0.00266	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CXCR3—atopic dermatitis	0.00036	0.00265	CbGpPWpGaD
Remifentanil—Syncope—Prednisolone—atopic dermatitis	0.000359	0.000935	CcSEcCtD
Remifentanil—OPRK1—Signaling by GPCR—CCL27—atopic dermatitis	0.000359	0.00264	CbGpPWpGaD
Remifentanil—Loss of consciousness—Prednisolone—atopic dermatitis	0.000352	0.000916	CcSEcCtD
Remifentanil—Syncope—Hydrocortisone—atopic dermatitis	0.000351	0.000913	CcSEcCtD
Remifentanil—Diarrhoea—Tacrolimus—atopic dermatitis	0.00035	0.000912	CcSEcCtD
Remifentanil—OPRM1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.00035	0.00258	CbGpPWpGaD
Remifentanil—Angiopathy—Dexamethasone—atopic dermatitis	0.000349	0.000907	CcSEcCtD
Remifentanil—Angiopathy—Betamethasone—atopic dermatitis	0.000349	0.000907	CcSEcCtD
Remifentanil—OPRM1—GPCR ligand binding—CCR3—atopic dermatitis	0.000348	0.00256	CbGpPWpGaD
Remifentanil—Convulsion—Prednisolone—atopic dermatitis	0.000347	0.000903	CcSEcCtD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000346	0.00255	CbGpPWpGaD
Remifentanil—Hypertension—Prednisolone—atopic dermatitis	0.000346	0.0009	CcSEcCtD
Remifentanil—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000344	0.000895	CcSEcCtD
Remifentanil—Arrhythmia—Betamethasone—atopic dermatitis	0.000343	0.000893	CcSEcCtD
Remifentanil—Arrhythmia—Dexamethasone—atopic dermatitis	0.000343	0.000893	CcSEcCtD
Remifentanil—Bradycardia—Prednisone—atopic dermatitis	0.000341	0.000886	CcSEcCtD
Remifentanil—OPRM1—Signaling by GPCR—CCL22—atopic dermatitis	0.00034	0.0025	CbGpPWpGaD
Remifentanil—Convulsion—Hydrocortisone—atopic dermatitis	0.000339	0.000882	CcSEcCtD
Remifentanil—Dizziness—Tacrolimus—atopic dermatitis	0.000339	0.000881	CcSEcCtD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000338	0.00249	CbGpPWpGaD
Remifentanil—Hypertension—Hydrocortisone—atopic dermatitis	0.000338	0.000879	CcSEcCtD
Remifentanil—Haemoglobin—Prednisone—atopic dermatitis	0.000336	0.000875	CcSEcCtD
Remifentanil—Haemorrhage—Prednisone—atopic dermatitis	0.000335	0.00087	CcSEcCtD
Remifentanil—Erythema—Dexamethasone—atopic dermatitis	0.000334	0.00087	CcSEcCtD
Remifentanil—Erythema—Betamethasone—atopic dermatitis	0.000334	0.00087	CcSEcCtD
Remifentanil—OPRM1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000334	0.00246	CbGpPWpGaD
Remifentanil—Hallucination—Prednisone—atopic dermatitis	0.000333	0.000866	CcSEcCtD
Remifentanil—OPRD1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000332	0.00244	CbGpPWpGaD
Remifentanil—Anxiety—Hydrocortisone—atopic dermatitis	0.000332	0.000864	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000331	0.000861	CcSEcCtD
Remifentanil—Syncope—Triamcinolone—atopic dermatitis	0.000331	0.00086	CcSEcCtD
Remifentanil—Syncope—Methylprednisolone—atopic dermatitis	0.00033	0.000858	CcSEcCtD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000329	0.00242	CbGpPWpGaD
Remifentanil—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000327	0.000851	CcSEcCtD
Remifentanil—Oedema—Prednisolone—atopic dermatitis	0.000327	0.000851	CcSEcCtD
Remifentanil—Vomiting—Tacrolimus—atopic dermatitis	0.000326	0.000847	CcSEcCtD
Remifentanil—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000324	0.000843	CcSEcCtD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000323	0.00238	CbGpPWpGaD
Remifentanil—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000323	0.000841	CcSEcCtD
Remifentanil—Rash—Tacrolimus—atopic dermatitis	0.000323	0.00084	CcSEcCtD
Remifentanil—Dermatitis—Tacrolimus—atopic dermatitis	0.000323	0.000839	CcSEcCtD
Remifentanil—OPRK1—Signaling by GPCR—CCL17—atopic dermatitis	0.000322	0.00237	CbGpPWpGaD
Remifentanil—Shock—Prednisolone—atopic dermatitis	0.000322	0.000837	CcSEcCtD
Remifentanil—Cough—Triamcinolone—atopic dermatitis	0.000322	0.000837	CcSEcCtD
Remifentanil—Headache—Tacrolimus—atopic dermatitis	0.000321	0.000835	CcSEcCtD
Remifentanil—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000319	0.000831	CcSEcCtD
Remifentanil—Oedema—Hydrocortisone—atopic dermatitis	0.000319	0.000831	CcSEcCtD
Remifentanil—Convulsion—Triamcinolone—atopic dermatitis	0.000319	0.000831	CcSEcCtD
Remifentanil—Tachycardia—Prednisolone—atopic dermatitis	0.000319	0.00083	CcSEcCtD
Remifentanil—Convulsion—Methylprednisolone—atopic dermatitis	0.000319	0.000829	CcSEcCtD
Remifentanil—Hypertension—Triamcinolone—atopic dermatitis	0.000318	0.000828	CcSEcCtD
Remifentanil—Hypertension—Methylprednisolone—atopic dermatitis	0.000317	0.000826	CcSEcCtD
Remifentanil—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000316	0.000823	CcSEcCtD
Remifentanil—OPRM1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000315	0.00232	CbGpPWpGaD
Remifentanil—Shock—Hydrocortisone—atopic dermatitis	0.000314	0.000818	CcSEcCtD
Remifentanil—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000313	0.000815	CcSEcCtD
Remifentanil—Anxiety—Methylprednisolone—atopic dermatitis	0.000312	0.000812	CcSEcCtD
Remifentanil—Tachycardia—Hydrocortisone—atopic dermatitis	0.000312	0.000811	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000311	0.000809	CcSEcCtD
Remifentanil—OPRM1—GPCR ligand binding—NPS—atopic dermatitis	0.000311	0.00229	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—TAC1—atopic dermatitis	0.000311	0.00229	CbGpPWpGaD
Remifentanil—Flushing—Prednisone—atopic dermatitis	0.00031	0.000808	CcSEcCtD
Remifentanil—Skin disorder—Hydrocortisone—atopic dermatitis	0.00031	0.000807	CcSEcCtD
Remifentanil—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000309	0.000803	CcSEcCtD
Remifentanil—Dry mouth—Triamcinolone—atopic dermatitis	0.000307	0.000798	CcSEcCtD
Remifentanil—OPRD1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000305	0.00224	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000305	0.00224	CbGpPWpGaD
Remifentanil—Nausea—Tacrolimus—atopic dermatitis	0.000304	0.000791	CcSEcCtD
Remifentanil—Angiopathy—Prednisone—atopic dermatitis	0.000304	0.00079	CcSEcCtD
Remifentanil—OPRM1—Signaling by GPCR—CCL27—atopic dermatitis	0.000303	0.00223	CbGpPWpGaD
Remifentanil—Confusional state—Methylprednisolone—atopic dermatitis	0.000303	0.000787	CcSEcCtD
Remifentanil—Immune system disorder—Prednisone—atopic dermatitis	0.000302	0.000786	CcSEcCtD
Remifentanil—Oedema—Triamcinolone—atopic dermatitis	0.000301	0.000783	CcSEcCtD
Remifentanil—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000301	0.000783	CcSEcCtD
Remifentanil—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.0003	0.000781	CcSEcCtD
Remifentanil—Syncope—Betamethasone—atopic dermatitis	0.0003	0.00078	CcSEcCtD
Remifentanil—Syncope—Dexamethasone—atopic dermatitis	0.0003	0.00078	CcSEcCtD
Remifentanil—Arrhythmia—Prednisone—atopic dermatitis	0.000299	0.000778	CcSEcCtD
Remifentanil—Hypotension—Hydrocortisone—atopic dermatitis	0.000299	0.000777	CcSEcCtD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000297	0.00218	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCL11—atopic dermatitis	0.000296	0.00218	CbGpPWpGaD
Remifentanil—Shock—Triamcinolone—atopic dermatitis	0.000296	0.00077	CcSEcCtD
Remifentanil—Shock—Methylprednisolone—atopic dermatitis	0.000295	0.000768	CcSEcCtD
Remifentanil—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000294	0.000766	CcSEcCtD
Remifentanil—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000294	0.000765	CcSEcCtD
Remifentanil—Loss of consciousness—Betamethasone—atopic dermatitis	0.000294	0.000765	CcSEcCtD
Remifentanil—Paraesthesia—Prednisolone—atopic dermatitis	0.000294	0.000764	CcSEcCtD
Remifentanil—Tachycardia—Triamcinolone—atopic dermatitis	0.000294	0.000764	CcSEcCtD
Remifentanil—Tachycardia—Methylprednisolone—atopic dermatitis	0.000293	0.000762	CcSEcCtD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000293	0.00215	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FCER2—atopic dermatitis	0.000292	0.00215	CbGpPWpGaD
Remifentanil—Skin disorder—Methylprednisolone—atopic dermatitis	0.000292	0.000758	CcSEcCtD
Remifentanil—OPRK1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000291	0.00214	CbGpPWpGaD
Remifentanil—Erythema—Prednisone—atopic dermatitis	0.000291	0.000758	CcSEcCtD
Remifentanil—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000291	0.000756	CcSEcCtD
Remifentanil—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.00029	0.000755	CcSEcCtD
Remifentanil—Convulsion—Dexamethasone—atopic dermatitis	0.00029	0.000754	CcSEcCtD
Remifentanil—Convulsion—Betamethasone—atopic dermatitis	0.00029	0.000754	CcSEcCtD
Remifentanil—Hypertension—Betamethasone—atopic dermatitis	0.000289	0.000751	CcSEcCtD
Remifentanil—Hypertension—Dexamethasone—atopic dermatitis	0.000289	0.000751	CcSEcCtD
Remifentanil—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000287	0.000746	CcSEcCtD
Remifentanil—OPRD1—GPCR ligand binding—CCL5—atopic dermatitis	0.000286	0.0021	CbGpPWpGaD
Remifentanil—Anxiety—Betamethasone—atopic dermatitis	0.000284	0.000738	CcSEcCtD
Remifentanil—Anxiety—Dexamethasone—atopic dermatitis	0.000284	0.000738	CcSEcCtD
Remifentanil—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000281	0.000732	CcSEcCtD
Remifentanil—Hypotension—Methylprednisolone—atopic dermatitis	0.00028	0.00073	CcSEcCtD
Remifentanil—Pain—Prednisolone—atopic dermatitis	0.00028	0.000728	CcSEcCtD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000278	0.00205	CbGpPWpGaD
Remifentanil—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000276	0.000717	CcSEcCtD
Remifentanil—Pain—Hydrocortisone—atopic dermatitis	0.000273	0.000711	CcSEcCtD
Remifentanil—Oedema—Dexamethasone—atopic dermatitis	0.000273	0.00071	CcSEcCtD
Remifentanil—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000273	0.00071	CcSEcCtD
Remifentanil—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000273	0.00071	CcSEcCtD
Remifentanil—Oedema—Betamethasone—atopic dermatitis	0.000273	0.00071	CcSEcCtD
Remifentanil—OPRM1—Signaling by GPCR—CCL17—atopic dermatitis	0.000272	0.002	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCL22—atopic dermatitis	0.000271	0.002	CbGpPWpGaD
Remifentanil—Paraesthesia—Triamcinolone—atopic dermatitis	0.00027	0.000703	CcSEcCtD
Remifentanil—Feeling abnormal—Prednisolone—atopic dermatitis	0.00027	0.000701	CcSEcCtD
Remifentanil—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000269	0.000701	CcSEcCtD
Remifentanil—Anaemia—Prednisone—atopic dermatitis	0.000269	0.0007	CcSEcCtD
Remifentanil—Shock—Dexamethasone—atopic dermatitis	0.000269	0.000699	CcSEcCtD
Remifentanil—Shock—Betamethasone—atopic dermatitis	0.000269	0.000699	CcSEcCtD
Remifentanil—Dyspnoea—Triamcinolone—atopic dermatitis	0.000268	0.000698	CcSEcCtD
Remifentanil—Nervous system disorder—Betamethasone—atopic dermatitis	0.000268	0.000696	CcSEcCtD
Remifentanil—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000268	0.000696	CcSEcCtD
Remifentanil—Agitation—Prednisone—atopic dermatitis	0.000268	0.000696	CcSEcCtD
Remifentanil—OPRK1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000267	0.00197	CbGpPWpGaD
Remifentanil—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000267	0.000695	CcSEcCtD
Remifentanil—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000267	0.000695	CcSEcCtD
Remifentanil—Tachycardia—Betamethasone—atopic dermatitis	0.000266	0.000693	CcSEcCtD
Remifentanil—Tachycardia—Dexamethasone—atopic dermatitis	0.000266	0.000693	CcSEcCtD
Remifentanil—OPRD1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000266	0.00196	CbGpPWpGaD
Remifentanil—Dyspepsia—Triamcinolone—atopic dermatitis	0.000265	0.000689	CcSEcCtD
Remifentanil—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000264	0.000687	CcSEcCtD
Remifentanil—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000264	0.000686	CcSEcCtD
Remifentanil—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000264	0.000686	CcSEcCtD
Remifentanil—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000263	0.000685	CcSEcCtD
Remifentanil—Syncope—Prednisone—atopic dermatitis	0.000261	0.000679	CcSEcCtD
Remifentanil—Urticaria—Prednisolone—atopic dermatitis	0.00026	0.000676	CcSEcCtD
Remifentanil—OPRK1—Signaling by GPCR—CCL11—atopic dermatitis	0.00026	0.00191	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CCR5—atopic dermatitis	0.000258	0.0019	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000257	0.00189	CbGpPWpGaD
Remifentanil—Pain—Triamcinolone—atopic dermatitis	0.000257	0.000669	CcSEcCtD
Remifentanil—Loss of consciousness—Prednisone—atopic dermatitis	0.000256	0.000666	CcSEcCtD
Remifentanil—OPRK1—Signaling Pathways—FCER2—atopic dermatitis	0.000256	0.00188	CbGpPWpGaD
Remifentanil—Hypotension—Dexamethasone—atopic dermatitis	0.000255	0.000663	CcSEcCtD
Remifentanil—Hypotension—Betamethasone—atopic dermatitis	0.000255	0.000663	CcSEcCtD
Remifentanil—Urticaria—Hydrocortisone—atopic dermatitis	0.000254	0.00066	CcSEcCtD
Remifentanil—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000253	0.000657	CcSEcCtD
Remifentanil—Convulsion—Prednisone—atopic dermatitis	0.000252	0.000656	CcSEcCtD
Remifentanil—Hypertension—Prednisone—atopic dermatitis	0.000251	0.000654	CcSEcCtD
Remifentanil—OPRK1—GPCR ligand binding—CCL5—atopic dermatitis	0.000251	0.00185	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000251	0.00184	CbGpPWpGaD
Remifentanil—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000248	0.000645	CcSEcCtD
Remifentanil—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000247	0.000643	CcSEcCtD
Remifentanil—Anxiety—Prednisone—atopic dermatitis	0.000247	0.000643	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000246	0.000641	CcSEcCtD
Remifentanil—OPRM1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000246	0.00181	CbGpPWpGaD
Remifentanil—Paraesthesia—Dexamethasone—atopic dermatitis	0.000245	0.000638	CcSEcCtD
Remifentanil—Paraesthesia—Betamethasone—atopic dermatitis	0.000245	0.000638	CcSEcCtD
Remifentanil—OPRD1—Signaling Pathways—CCL27—atopic dermatitis	0.000242	0.00178	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCR3—atopic dermatitis	0.000241	0.00178	CbGpPWpGaD
Remifentanil—Hypersensitivity—Prednisolone—atopic dermatitis	0.000241	0.000627	CcSEcCtD
Remifentanil—Dyspepsia—Betamethasone—atopic dermatitis	0.00024	0.000625	CcSEcCtD
Remifentanil—Dyspepsia—Dexamethasone—atopic dermatitis	0.00024	0.000625	CcSEcCtD
Remifentanil—Urticaria—Triamcinolone—atopic dermatitis	0.000239	0.000622	CcSEcCtD
Remifentanil—Urticaria—Methylprednisolone—atopic dermatitis	0.000238	0.00062	CcSEcCtD
Remifentanil—OPRK1—Signaling Pathways—CCL22—atopic dermatitis	0.000238	0.00175	CbGpPWpGaD
Remifentanil—Body temperature increased—Triamcinolone—atopic dermatitis	0.000238	0.000619	CcSEcCtD
Remifentanil—Oedema—Prednisone—atopic dermatitis	0.000238	0.000618	CcSEcCtD
Remifentanil—Anaphylactic shock—Prednisone—atopic dermatitis	0.000238	0.000618	CcSEcCtD
Remifentanil—OPRD1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000237	0.00174	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—NPS—atopic dermatitis	0.000237	0.00174	CbGpPWpGaD
Remifentanil—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000236	0.000613	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000236	0.000613	CcSEcCtD
Remifentanil—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000235	0.000612	CcSEcCtD
Remifentanil—Shock—Prednisone—atopic dermatitis	0.000234	0.000608	CcSEcCtD
Remifentanil—Pain—Betamethasone—atopic dermatitis	0.000233	0.000607	CcSEcCtD
Remifentanil—Pain—Dexamethasone—atopic dermatitis	0.000233	0.000607	CcSEcCtD
Remifentanil—Nervous system disorder—Prednisone—atopic dermatitis	0.000233	0.000606	CcSEcCtD
Remifentanil—OPRK1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000233	0.00171	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000232	0.00171	CbGpPWpGaD
Remifentanil—Tachycardia—Prednisone—atopic dermatitis	0.000232	0.000603	CcSEcCtD
Remifentanil—Skin disorder—Prednisone—atopic dermatitis	0.000231	0.000601	CcSEcCtD
Remifentanil—OPRM1—TCR Signaling Pathway—IL6—atopic dermatitis	0.000231	0.0017	CbGpPWpGaD
Remifentanil—Hyperhidrosis—Prednisone—atopic dermatitis	0.00023	0.000598	CcSEcCtD
Remifentanil—Pruritus—Hydrocortisone—atopic dermatitis	0.000226	0.000588	CcSEcCtD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000226	0.00166	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CCR5—atopic dermatitis	0.000226	0.00166	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000226	0.00166	CbGpPWpGaD
Remifentanil—Feeling abnormal—Betamethasone—atopic dermatitis	0.000225	0.000585	CcSEcCtD
Remifentanil—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000225	0.000585	CcSEcCtD
Remifentanil—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000222	0.000577	CcSEcCtD
Remifentanil—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000221	0.000575	CcSEcCtD
Remifentanil—OPRD1—GPCR downstream signaling—IL5—atopic dermatitis	0.00022	0.00162	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCL11—atopic dermatitis	0.000219	0.00161	CbGpPWpGaD
Remifentanil—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000219	0.000569	CcSEcCtD
Remifentanil—OPRD1—Signaling Pathways—CCL17—atopic dermatitis	0.000217	0.0016	CbGpPWpGaD
Remifentanil—Urticaria—Betamethasone—atopic dermatitis	0.000217	0.000564	CcSEcCtD
Remifentanil—Urticaria—Dexamethasone—atopic dermatitis	0.000217	0.000564	CcSEcCtD
Remifentanil—OPRM1—Signaling Pathways—FCER2—atopic dermatitis	0.000216	0.00159	CbGpPWpGaD
Remifentanil—Dizziness—Prednisolone—atopic dermatitis	0.000216	0.000563	CcSEcCtD
Remifentanil—Body temperature increased—Betamethasone—atopic dermatitis	0.000216	0.000561	CcSEcCtD
Remifentanil—Body temperature increased—Dexamethasone—atopic dermatitis	0.000216	0.000561	CcSEcCtD
Remifentanil—OPRD1—Signaling by GPCR—NPS—atopic dermatitis	0.000215	0.00158	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—TAC1—atopic dermatitis	0.000215	0.00158	CbGpPWpGaD
Remifentanil—Paraesthesia—Prednisone—atopic dermatitis	0.000213	0.000555	CcSEcCtD
Remifentanil—Pruritus—Triamcinolone—atopic dermatitis	0.000213	0.000554	CcSEcCtD
Remifentanil—Pruritus—Methylprednisolone—atopic dermatitis	0.000212	0.000552	CcSEcCtD
Remifentanil—OPRK1—Signaling Pathways—CCL27—atopic dermatitis	0.000212	0.00156	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CCL5—atopic dermatitis	0.000212	0.00156	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCR3—atopic dermatitis	0.000212	0.00156	CbGpPWpGaD
Remifentanil—Dizziness—Hydrocortisone—atopic dermatitis	0.000211	0.00055	CcSEcCtD
Remifentanil—OPRD1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000211	0.00155	CbGpPWpGaD
Remifentanil—Dyspepsia—Prednisone—atopic dermatitis	0.000209	0.000544	CcSEcCtD
Remifentanil—OPRK1—GPCR downstream signaling—NPS—atopic dermatitis	0.000208	0.00153	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000208	0.00153	CbGpPWpGaD
Remifentanil—Rash—Prednisolone—atopic dermatitis	0.000206	0.000537	CcSEcCtD
Remifentanil—Dermatitis—Prednisolone—atopic dermatitis	0.000206	0.000536	CcSEcCtD
Remifentanil—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000205	0.000534	CcSEcCtD
Remifentanil—Headache—Prednisolone—atopic dermatitis	0.000205	0.000533	CcSEcCtD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000205	0.00151	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000204	0.0015	CbGpPWpGaD
Remifentanil—Constipation—Prednisone—atopic dermatitis	0.000203	0.000529	CcSEcCtD
Remifentanil—Vomiting—Hydrocortisone—atopic dermatitis	0.000203	0.000528	CcSEcCtD
Remifentanil—Rash—Hydrocortisone—atopic dermatitis	0.000201	0.000524	CcSEcCtD
Remifentanil—Dermatitis—Hydrocortisone—atopic dermatitis	0.000201	0.000524	CcSEcCtD
Remifentanil—OPRM1—Signaling Pathways—CCL22—atopic dermatitis	0.000201	0.00148	CbGpPWpGaD
Remifentanil—Headache—Hydrocortisone—atopic dermatitis	0.0002	0.000521	CcSEcCtD
Remifentanil—OPRD1—Signaling by GPCR—IL5—atopic dermatitis	0.0002	0.00147	CbGpPWpGaD
Remifentanil—Dizziness—Triamcinolone—atopic dermatitis	0.000199	0.000517	CcSEcCtD
Remifentanil—Dizziness—Methylprednisolone—atopic dermatitis	0.000198	0.000516	CcSEcCtD
Remifentanil—OPRM1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000197	0.00145	CbGpPWpGaD
Remifentanil—Feeling abnormal—Prednisone—atopic dermatitis	0.000196	0.00051	CcSEcCtD
Remifentanil—Nausea—Prednisolone—atopic dermatitis	0.000194	0.000505	CcSEcCtD
Remifentanil—OPRD1—Signaling Pathways—KIF3A—atopic dermatitis	0.000193	0.00142	CbGpPWpGaD
Remifentanil—Pruritus—Betamethasone—atopic dermatitis	0.000193	0.000502	CcSEcCtD
Remifentanil—Pruritus—Dexamethasone—atopic dermatitis	0.000193	0.000502	CcSEcCtD
Remifentanil—OPRK1—GPCR downstream signaling—IL5—atopic dermatitis	0.000193	0.00142	CbGpPWpGaD
Remifentanil—Vomiting—Triamcinolone—atopic dermatitis	0.000191	0.000498	CcSEcCtD
Remifentanil—OPRM1—GPCR ligand binding—CCR5—atopic dermatitis	0.000191	0.0014	CbGpPWpGaD
Remifentanil—Vomiting—Methylprednisolone—atopic dermatitis	0.000191	0.000496	CcSEcCtD
Remifentanil—OPRM1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000191	0.0014	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL17—atopic dermatitis	0.00019	0.0014	CbGpPWpGaD
Remifentanil—Nausea—Hydrocortisone—atopic dermatitis	0.00019	0.000494	CcSEcCtD
Remifentanil—Rash—Triamcinolone—atopic dermatitis	0.00019	0.000493	CcSEcCtD
Remifentanil—Dermatitis—Triamcinolone—atopic dermatitis	0.000189	0.000493	CcSEcCtD
Remifentanil—Rash—Methylprednisolone—atopic dermatitis	0.000189	0.000492	CcSEcCtD
Remifentanil—Dermatitis—Methylprednisolone—atopic dermatitis	0.000189	0.000492	CcSEcCtD
Remifentanil—Urticaria—Prednisone—atopic dermatitis	0.000189	0.000491	CcSEcCtD
Remifentanil—OPRK1—Signaling by GPCR—NPS—atopic dermatitis	0.000189	0.00139	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—TAC1—atopic dermatitis	0.000189	0.00139	CbGpPWpGaD
Remifentanil—Headache—Triamcinolone—atopic dermatitis	0.000188	0.00049	CcSEcCtD
Remifentanil—Headache—Methylprednisolone—atopic dermatitis	0.000188	0.000489	CcSEcCtD
Remifentanil—Body temperature increased—Prednisone—atopic dermatitis	0.000188	0.000489	CcSEcCtD
Remifentanil—OPRD1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000188	0.00138	CbGpPWpGaD
Remifentanil—Diarrhoea—Betamethasone—atopic dermatitis	0.000187	0.000486	CcSEcCtD
Remifentanil—Diarrhoea—Dexamethasone—atopic dermatitis	0.000187	0.000486	CcSEcCtD
Remifentanil—OPRK1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000185	0.00136	CbGpPWpGaD
Remifentanil—Dizziness—Dexamethasone—atopic dermatitis	0.00018	0.00047	CcSEcCtD
Remifentanil—Dizziness—Betamethasone—atopic dermatitis	0.00018	0.00047	CcSEcCtD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000179	0.00132	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL27—atopic dermatitis	0.000179	0.00132	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCR3—atopic dermatitis	0.000179	0.00132	CbGpPWpGaD
Remifentanil—Nausea—Triamcinolone—atopic dermatitis	0.000179	0.000465	CcSEcCtD
Remifentanil—Nausea—Methylprednisolone—atopic dermatitis	0.000178	0.000464	CcSEcCtD
Remifentanil—OPRM1—GPCR downstream signaling—NPS—atopic dermatitis	0.000176	0.00129	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000176	0.00129	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL5—atopic dermatitis	0.000175	0.00129	CbGpPWpGaD
Remifentanil—Hypersensitivity—Prednisone—atopic dermatitis	0.000175	0.000456	CcSEcCtD
Remifentanil—OPRD1—Signaling Pathways—CMA1—atopic dermatitis	0.000175	0.00129	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCL11—atopic dermatitis	0.000175	0.00129	CbGpPWpGaD
Remifentanil—Vomiting—Betamethasone—atopic dermatitis	0.000174	0.000451	CcSEcCtD
Remifentanil—Vomiting—Dexamethasone—atopic dermatitis	0.000174	0.000451	CcSEcCtD
Remifentanil—OPRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000172	0.00127	CbGpPWpGaD
Remifentanil—Rash—Dexamethasone—atopic dermatitis	0.000172	0.000448	CcSEcCtD
Remifentanil—Rash—Betamethasone—atopic dermatitis	0.000172	0.000448	CcSEcCtD
Remifentanil—Dermatitis—Dexamethasone—atopic dermatitis	0.000172	0.000447	CcSEcCtD
Remifentanil—Dermatitis—Betamethasone—atopic dermatitis	0.000172	0.000447	CcSEcCtD
Remifentanil—Headache—Dexamethasone—atopic dermatitis	0.000171	0.000445	CcSEcCtD
Remifentanil—Headache—Betamethasone—atopic dermatitis	0.000171	0.000445	CcSEcCtD
Remifentanil—OPRD1—Signaling by GPCR—CXCL10—atopic dermatitis	0.00017	0.00125	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KIF3A—atopic dermatitis	0.00017	0.00125	CbGpPWpGaD
Remifentanil—Pruritus—Prednisone—atopic dermatitis	0.000168	0.000437	CcSEcCtD
Remifentanil—OPRK1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000165	0.00121	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—STAT6—atopic dermatitis	0.000164	0.00121	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—IL5—atopic dermatitis	0.000163	0.0012	CbGpPWpGaD
Remifentanil—Diarrhoea—Prednisone—atopic dermatitis	0.000163	0.000423	CcSEcCtD
Remifentanil—Nausea—Dexamethasone—atopic dermatitis	0.000162	0.000422	CcSEcCtD
Remifentanil—Nausea—Betamethasone—atopic dermatitis	0.000162	0.000422	CcSEcCtD
Remifentanil—OPRD1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000162	0.00119	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL17—atopic dermatitis	0.000161	0.00118	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—NPS—atopic dermatitis	0.000159	0.00117	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—TAC1—atopic dermatitis	0.000159	0.00117	CbGpPWpGaD
Remifentanil—Dizziness—Prednisone—atopic dermatitis	0.000157	0.000409	CcSEcCtD
Remifentanil—OPRM1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000156	0.00115	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000156	0.00115	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CMA1—atopic dermatitis	0.000153	0.00113	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL11—atopic dermatitis	0.000153	0.00113	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000152	0.00112	CbGpPWpGaD
Remifentanil—Vomiting—Prednisone—atopic dermatitis	0.000151	0.000393	CcSEcCtD
Remifentanil—Rash—Prednisone—atopic dermatitis	0.00015	0.00039	CcSEcCtD
Remifentanil—Dermatitis—Prednisone—atopic dermatitis	0.00015	0.00039	CcSEcCtD
Remifentanil—OPRK1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000149	0.0011	CbGpPWpGaD
Remifentanil—Headache—Prednisone—atopic dermatitis	0.000149	0.000387	CcSEcCtD
Remifentanil—OPRM1—Signaling by GPCR—IL5—atopic dermatitis	0.000148	0.00109	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCL5—atopic dermatitis	0.000147	0.00108	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000146	0.00107	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—STAT6—atopic dermatitis	0.000144	0.00106	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KIF3A—atopic dermatitis	0.000143	0.00105	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCR3—atopic dermatitis	0.000143	0.00105	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000142	0.00104	CbGpPWpGaD
Remifentanil—Nausea—Prednisone—atopic dermatitis	0.000141	0.000367	CcSEcCtD
Remifentanil—OPRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000139	0.00102	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000137	0.001	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCR5—atopic dermatitis	0.000132	0.000973	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL11—atopic dermatitis	0.00013	0.000954	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CMA1—atopic dermatitis	0.00013	0.000954	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCL5—atopic dermatitis	0.000129	0.000947	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000128	0.000939	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TAC1—atopic dermatitis	0.000127	0.000935	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NPS—atopic dermatitis	0.000127	0.000935	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000126	0.00093	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCR3—atopic dermatitis	0.000125	0.00092	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCR3—atopic dermatitis	0.000125	0.000917	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—STAT6—atopic dermatitis	0.000122	0.000896	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CCL5—atopic dermatitis	0.00012	0.000881	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL5—atopic dermatitis	0.000118	0.000869	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCR5—atopic dermatitis	0.000116	0.000853	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000115	0.000849	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TAC1—atopic dermatitis	0.000111	0.00082	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NPS—atopic dermatitis	0.000111	0.00082	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCR3—atopic dermatitis	0.000109	0.000804	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCL5—atopic dermatitis	0.000109	0.0008	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000108	0.000794	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCR3—atopic dermatitis	0.000106	0.000777	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL5—atopic dermatitis	0.000104	0.000762	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCL10—atopic dermatitis	0.000101	0.000741	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCR5—atopic dermatitis	9.8e-05	0.000721	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NPS—atopic dermatitis	9.42e-05	0.000693	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TAC1—atopic dermatitis	9.42e-05	0.000693	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCR3—atopic dermatitis	9.23e-05	0.000679	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCL10—atopic dermatitis	8.83e-05	0.00065	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	8.8e-05	0.000648	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL5—atopic dermatitis	8.75e-05	0.000644	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCL5—atopic dermatitis	8.67e-05	0.000638	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—IL2—atopic dermatitis	8.41e-05	0.000619	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NGF—atopic dermatitis	8.03e-05	0.000591	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CXCL8—atopic dermatitis	7.99e-05	0.000588	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCR5—atopic dermatitis	7.81e-05	0.000575	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CXCL8—atopic dermatitis	7.72e-05	0.000568	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL2—atopic dermatitis	7.64e-05	0.000562	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL5—atopic dermatitis	7.6e-05	0.000559	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL10—atopic dermatitis	7.46e-05	0.000549	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—IL2—atopic dermatitis	7.38e-05	0.000543	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NGF—atopic dermatitis	7.04e-05	0.000518	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CXCL8—atopic dermatitis	7.01e-05	0.000516	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCR5—atopic dermatitis	6.85e-05	0.000504	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL2—atopic dermatitis	6.7e-05	0.000493	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NFKBIA—atopic dermatitis	6.62e-05	0.000487	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	6.52e-05	0.00048	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL5—atopic dermatitis	6.42e-05	0.000473	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—IL2—atopic dermatitis	6.23e-05	0.000459	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NGF—atopic dermatitis	5.95e-05	0.000438	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CXCL8—atopic dermatitis	5.92e-05	0.000436	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NFKBIA—atopic dermatitis	5.81e-05	0.000427	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCR5—atopic dermatitis	5.79e-05	0.000426	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL2—atopic dermatitis	5.66e-05	0.000417	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NFKBIA—atopic dermatitis	4.91e-05	0.000361	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCL8—atopic dermatitis	4.72e-05	0.000347	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL2—atopic dermatitis	4.51e-05	0.000332	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL6—atopic dermatitis	4.49e-05	0.00033	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAPK8—atopic dermatitis	4.15e-05	0.000306	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCL8—atopic dermatitis	4.14e-05	0.000305	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL2—atopic dermatitis	3.96e-05	0.000291	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6—atopic dermatitis	3.94e-05	0.00029	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAPK8—atopic dermatitis	3.64e-05	0.000268	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL8—atopic dermatitis	3.5e-05	0.000257	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL2—atopic dermatitis	3.34e-05	0.000246	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6—atopic dermatitis	3.33e-05	0.000245	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAPK8—atopic dermatitis	3.08e-05	0.000227	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6—atopic dermatitis	2.65e-05	0.000195	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6—atopic dermatitis	2.33e-05	0.000171	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6—atopic dermatitis	1.97e-05	0.000145	CbGpPWpGaD
